Australia  

Johnson & Johnson to pay $2.6 million for faulty pelvic mesh implants

The Age Tuesday, 3 March 2020
The Federal Court ordered the pharmaceutical giant and two affiliated companies to pay the damages to three women at the centre of a landmark class action.
0
shares
ShareTweetSavePostSend
 

💡 One News Page Knowledge: Other News Mentions

Johnson & Johnson Johnson & Johnson U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Johnson & Johnson Cease Production Of Lightening Products [Video]

Johnson & Johnson Cease Production Of Lightening Products

The corporation behind Johnson's, Neutrogena, Clean & Clear, and more has just vowed to stop selling two lines of skin-care products used for skin-lightening overseas. On June 19, in the wake of the recent Black Lives Matter uprising, Johnson & Johnson said that it will cease production of two different lines from Asian and Middle Eastern markets that were used for skin-lightening lines.

Credit: Wochit News    Duration: 00:33Published
Band-Aid to Make Black and Brown Flesh-Tone Bandages [Video]

Band-Aid to Make Black and Brown Flesh-Tone Bandages

The Johnson & Johnson-owned company plans to create a range of bandages to "embrace the beauty of diverse skin"

Credit: Cover Video STUDIO    Duration: 00:50Published
Johnson & Johnson Speeds Up Vaccine Timeline [Video]

Johnson & Johnson Speeds Up Vaccine Timeline

Johnson & Johnson plans to start testing its coronavirus vaccine candidate in humans in July. The company said it will move up the timeline by about two months to start clinical trials. Previously the aim was to enter the clinic with the vaccine in September. The study will start in the second half of July and enroll 1,045 healthy volunteers in the US and Belgium. If the vaccine works, Johnson & Johnson has already pledged to distribute it at a nonprofit rate to help end the pandemic.

Credit: Wochit News    Duration: 00:35Published
Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine [Video]

Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine

The early-stage human trial will begin in the second half of July as opposed to its initial forecast of September.

Credit: Cover Video STUDIO    Duration: 00:56Published
Johnson & Johnson Moves Up Dates Of Human Testing For Covid Vaccine (1) [Video]

Johnson & Johnson Moves Up Dates Of Human Testing For Covid Vaccine (1)

Johnson & Johnson is the world's largest health care company. Business Insider reports that the company plans to start testing its coronavirus vaccine candidate in humans in July. On Wednesday, Johnson & Johnson it will move up the timeline by about two months to start clinical trials. It was previously aiming for trials in September. 1,045 healthy volunteers in the US and Belgium will join the study, which starts in July.

Credit: Wochit News    Duration: 00:34Published

You Might Like


Related news from verified sources

Johnson & Johnson to pay out $2.6m over vaginal mesh implants

The Federal Court has ordered US pharmaceutical giant Johnson & Johnson to pay $2.6 million in damages to three Australian women who received faulty pelvic mesh...
SBS


Tweets about this